Search hospitals > Texas > San Antonio
Methodist Children's Hospital of South Texas
Claim this profileSan Antonio, Texas 78229
Global Leader in Uterine Tumors
Global Leader in T-Lymphoblastic Leukemia/Lymphoma
Conducts research for Lymphoma
Conducts research for Cancer
Conducts research for Acute Lymphoblastic Leukemia
185 reported clinical trials
2 medical researchers
Summary
Methodist Children's Hospital of South Texas is a medical facility located in San Antonio, Texas. This center is recognized for care of Uterine Tumors, T-Lymphoblastic Leukemia/Lymphoma, Lymphoma, Cancer, Acute Lymphoblastic Leukemia and other specialties. Methodist Children's Hospital of South Texas is involved with conducting 185 clinical trials across 357 conditions. There are 2 research doctors associated with this hospital, such as Jose M. Esquilin and Vinod K. Gidvani-Diaz.Area of expertise
1Uterine Tumors
Global LeaderStage IV
Stage I
Stage II
2T-Lymphoblastic Leukemia/Lymphoma
Global LeaderStage II
Stage I
Stage IV
Top PIs
Jose M. EsquilinMethodist Children's Hospital of South Texas5 years of reported clinical research
Expert in Uterine Tumors
Expert in Cancer
51 reported clinical trials
105 drugs studied
Vinod K. Gidvani-DiazMethodist Children's Hospital of South Texas7 years of reported clinical research
Expert in Cancer
Expert in Uterine Tumors
41 reported clinical trials
100 drugs studied
Clinical Trials running at Methodist Children's Hospital of South Texas
Testicular cancer
Acute Lymphoblastic Leukemia
Wilms Tumor
Uterine Tumors
T-Lymphoblastic Leukemia/Lymphoma
Acute Myeloid Leukemia
Lymphoma
Germ Cell Tumors
Ovarian Tumors
Ovarian Choriocarcinoma
Chemotherapy
for Cancer
This phase III trial studies how well active surveillance help doctors to monitor subjects with low risk germ cell tumors for recurrence after their tumor is removed. When the germ cell tumor has spread outside of the organ in which it developed, it is considered metastatic. Chemotherapy drugs, such as bleomycin, carboplatin, etoposide, and cisplatin, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. The trial studies whether carboplatin or cisplatin is the preferred chemotherapy to use in treating metastatic standard risk germ cell tumors.
Recruiting2 awards Phase 326 criteria
Chemotherapy + Radiation Therapy
for Brain Cancer
This phase II trial studies the best approach to combine chemotherapy and radiation therapy (RT) based on the patient's response to induction chemotherapy in patients with non-germinomatous germ cell tumors (NGGCT) that have not spread to other parts of the brain or body (localized). This study has 2 goals: 1) optimizing radiation for patients who respond well to induction chemotherapy to diminish spinal cord relapses, 2) utilizing higher dose chemotherapy followed by conventional RT in patients who did not respond to induction chemotherapy. Chemotherapy drugs, such as carboplatin, etoposide, ifosfamide, and thiotepa, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Radiation therapy uses high energy x-rays or high-energy protons to kill tumor cells and shrink tumors. Studies have shown that patients with newly-diagnosed localized NGGCT, whose disease responds well to chemotherapy before receiving radiation therapy, are more likely to be free of the disease for a longer time than are patients for whom the chemotherapy does not efficiently eliminate or reduce the size of the tumor. The purpose of this study is to see how well the tumors respond to induction chemotherapy to decide what treatment to give next. Some patients will be given RT to the spine and a portion of the brain. Others will be given high dose chemotherapy and a stem cell transplant before RT to the whole brain and spine. Giving treatment based on the response to induction chemotherapy may lower the side effects of radiation in some patients and adjust the therapy to a more efficient one for other patients with localized NGGCT.
Recruiting1 award Phase 2
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at Methodist Children's Hospital of South Texas?
Methodist Children's Hospital of South Texas is a medical facility located in San Antonio, Texas. This center is recognized for care of Uterine Tumors, T-Lymphoblastic Leukemia/Lymphoma, Lymphoma, Cancer, Acute Lymphoblastic Leukemia and other specialties. Methodist Children's Hospital of South Texas is involved with conducting 185 clinical trials across 357 conditions. There are 2 research doctors associated with this hospital, such as Jose M. Esquilin and Vinod K. Gidvani-Diaz.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.